The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation
Young-Hoon Kim, Seung-Young Roh
J Stroke. 2016;18(2):129-137.   Published online 2016 May 31     DOI:
Citations to this article as recorded by Crossref logo
Protective effects of tetramethylpyrazine analogue Z-11 on cerebral ischemia reperfusion injury
Zhai Li, Jia Yulei, Ji Yaqing, Zou Jinmin, Liu Xinyong, Gao Jing, Liu Min
European Journal of Pharmacology.2019; 844: 156.     CrossRef
Biomarkers Associated with Stroke Risk in Atrial Fibrillation
Adam Ioannou, Nikolaos Papageorgiou, Debbie Falconer, Onkar Rehal, Emma Sewart, Effimia Zacharia, Konstantinos Toutouzas, Charalambos Vlachopoulos, Gerasimos Siasos, Costas Tsioufis, Dimitris Tousoulis
Current Medicinal Chemistry.2019; 26(5): 803.     CrossRef
The relationship between brain microbleeds and homeostatic markers in the treatment of ischemic stroke
O. Altintas, E. Niftaliyev, T. Asil
Neurological Research.2018; 40(12): 1048.     CrossRef
Picroside II protects the blood-brain barrier by inhibiting the oxidative signaling pathway in cerebral ischemia-reperfusion injury
Li Zhai, Min Liu, Tingting Wang, Hongyan Zhang, Shan Li, Yunliang Guo, Muzamil Ahmad
PLOS ONE.2017; 12(4): e0174414.     CrossRef
Platelet function and microparticle levels in atrial fibrillation: Changes during the acute episode
Line Pourtau, Jean Marc Sellal, Romaric Lacroix, Philippe Poncelet, Olivier Bernus, Gisèle Clofent-Sanchez, Mélèze Hocini, Michel Haïssaguerre, Françoise Dignat-George, Frédéric Sacher, Paquita Nurden
International Journal of Cardiology.2017; 243: 216.     CrossRef
Antiplatelet therapy for preventing stroke in people with atrial fibrillation
William K Karlsson, Jakob S Jensen, Janus C Jakobsen
Cochrane Database of Systematic Reviews.2016;[Epub]     CrossRef